News
2424 posts · page 68 of 101
AI Technology Uncovers Cancer Stem Cells, Revolutionizes Treatment
New AI framework detects elusive cancer stem cells, paving the way for personalized medicine.
AI Identifies Cancer Stem Cells, Advancing Precision Medicine
AI has revealed hidden cancer stem cells linked to tumor recurrence, offering new paths for targeted treatments.
Himachal Pradesh Explores Gene Therapy, Phototherapy with US Collaboration
Himachal Pradesh government is advancing gene therapy and phototherapy initiatives through discussions with US medical experts.
PTC Therapeutics Acquires ST-920 to Boost Rare Disease Treatments
PTC Therapeutics expands its rare disease portfolio by acquiring ST-920, a promising Fabry disease treatment.
Taysha Gene Therapies Stock Declines Amid Investor Concerns
Taysha Gene Therapies' shares fell sharply today, driven by investor worries over recent financial disclosures.
Molbio Diagnostics Targets ₹940 Crore in IPO to Boost Global Reach
Molbio Diagnostics plans to raise ₹940 crore through an IPO to fund expansion and reduce promoter stake.
India's Medical Device Sector Challenges Draft Bill's Pharma Alignment
Medical device firms protest India's draft bill equating devices to drugs, fearing innovation and investment setbacks.
Molbio Diagnostics Seeks ₹200 Crore in IPO for Expansion and Stake Sale
Molbio Diagnostics plans to raise ₹940 crore through an IPO, targeting growth in diagnostic solutions.
Medical Device Firms Challenge Proposed Indian Regulatory Bill
India's medical device sector opposes a draft bill equating devices with pharmaceuticals, citing potential harm to innovation and investment.
Understanding the Transmission Pathways of the Zika Virus
The Zika virus spreads primarily through mosquito bites but also via sexual contact and from mother to child.
France Reports 15 Cases of Locally Acquired Chikungunya
France has identified 15 locally acquired chikungunya cases, sparking health concerns.
WHO Intensifies Efforts to Combat Global Zika Virus Threat
The World Health Organization is ramping up initiatives to address the growing global threat posed by the Zika virus.
India's Nipah Virus: Insights from Repeated Spillovers
Recurrent Nipah outbreaks in India highlight geographical and ecological factors driving virus transmission.
WHO Urges Vigilance as Nipah Virus Threat Persists
The WHO highlights the persistent threat of the Nipah virus, urging global vigilance and preparedness.
Nipah Virus Case Sparks Health Alert in Kerala, India
Kerala confirms a new Nipah virus case, prompting health vigilance and containment measures.
Molbio Diagnostics Targets ₹940 Crore in IPO for Growth and Expansion
Molbio Diagnostics aims to raise ₹940 crore through an IPO, focusing on capital expansion and reducing promoter stake.
Industry Pushback: Medical Devices Not Pharmaceuticals, Say Companies
India's medical device sector opposes the draft bill equating devices with drugs, citing potential harm to innovation and investment.
Molbio Diagnostics Targets ₹940 Crore with Ambitious IPO Plan
Molbio Diagnostics aims to raise ₹940 crore through an IPO to fund expansion and reduce promoter stake.
Industry Pushes Back Against India's Draft Bill on Medical Devices
India's medical device sector criticizes the draft bill for equating devices with pharmaceuticals, warning it could stifle innovation.
Molbio Diagnostics Targets ₹940 Crore Through IPO
Molbio Diagnostics seeks to raise ₹940 crore via IPO, aiming to expand capital and reduce promoter stake.
Medical Device Industry Challenges Draft Bill's Pharma-Like Regulations
India's medical device sector opposes a draft bill that equates devices with drugs, fearing it will stifle innovation and investment.
Molbio Diagnostics IPO: A High-Risk Bet for Future Growth?
Molbio Diagnostics plans to raise ₹200 crore via fresh shares and ₹740 crore through an offer for sale. High-risk investors weigh long-term growth potential.
India's Medical Device Sector Opposes New Regulatory Draft Bill
India's medical device industry opposes the draft bill treating devices like drugs, citing risks to innovation and investment.
Molbio Diagnostics IPO Eyes ₹940 Crore for Expansion and Stake Reduction
Molbio Diagnostics plans an IPO to raise ₹940 crore for capital expansion and promoter stake reduction. The firm's growth hinges on its diagnostic test kits.